Management of SSRI-Induced sexual dysfunction

被引:37
|
作者
Woodrum, ST
Brown, CS
机构
[1] Univ Tennessee, Dept Pharm Practice, Memphis, TN 38163 USA
[2] Med Univ S Carolina, Dept Pharm, Psychiat Serv, Charleston, SC 29425 USA
[3] Univ Tennessee, Dept Pharmacoecon, Memphis, TN 38163 USA
关键词
antidepressants; selective serotonin reuptake inhibitors; sexual dysfunction;
D O I
10.1345/aph.17428
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: TO describe the occurrence and management of sexual dysfunction induced by selective serotonin-reuptake inhibitors (SSRIs), to provide an overview of sexual dysfunction, reports of SSRI-induced sexual dysfunction, and management strategies. DATA SOURCES: Information was retrieved from a MEDLINE English-literature search from January 1986 to July 1998 and by review of references. Indexing terms included sexual dysfunction, antidepressants, selective serotonergic reuptake inhibitors, fluoxetine, sertraline, paroxetine, fluvoxamine, clomipramine, buspirone, nefazodone, bupropion, cyproheptadine, amantadine, yohimbine, and central nervous system stimulants. STUDY SELECTION: There are no controlled studies describing SSRI-induced sexual dysfunction or its management. Twenty-one studies are presented, including 2 open-label studies, 12 case series, and 7 case reports. SSRI-induced sexual dysfunction is described with fluoxetine, paroxetine, sertraline, and fluvoxamine for 3-24 weeks of therapy. DATA SYNTHESIS: Data were organized according to the pharmacologic agent used in the management of SSRI dysfunction, target population, SSRI implicated, type of sexual dysfunction, experimental design, and treatment response. Data were extracted from methodology and results sections of reports. Methodologic flaws included failure to account for gender differences, omission of SSRI dose and duration, and use of concomitant drugs. CONCLUSIONS: The frequency of reports suggests that SSRI-induced dysfunction is a common adverse effect; controlled studies are necessary to determine prevalence. Most reports have occurred with fluoxetine, but this phenomenon may be related to its widespread use. Further study is needed to evaluate baseline sexual function, to define target populations, and to compare SSRIs in inducing sexual dysfunction. Serotonin antagonists and dopamine agonists have been used most often to treat SSRI-induced dysfunction and have generally been effective, but controlled studies are also needed.
引用
收藏
页码:1209 / 1215
页数:7
相关论文
共 50 条
  • [31] SSRI-induced sexual dysfunction: Fluoxetime, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients
    MontejoGonzalez, AL
    Liorca, G
    Izquierdo, JA
    Ledesma, A
    Bousono, M
    Calcedo, A
    Carrasco, JL
    Ciudad, J
    Daniel, E
    DeLaGandara, J
    Derecho, J
    Franco, M
    Gomez, MJ
    Macias, JA
    Martin, T
    Perez, V
    Sanchez, JM
    Sanchez, S
    Vicens, E
    JOURNAL OF SEX & MARITAL THERAPY, 1997, 23 (03) : 176 - 194
  • [32] SSRI-induced SIADH in older people
    Christe, C
    Vogt, N
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (05) : 630 - 631
  • [33] SSRI-Induced enuresis - A case report
    Monji, A
    Yanagimoto, K
    Yoshida, I
    Hashioka, S
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (05) : 564 - 565
  • [34] Relationship between SSRI-induced sexual dysfunction and central serotonergic activity based on the loudness dependence of auditory evoked potentials
    Young-Min Park
    Psychopharmacology, 2014, 231 : 551 - 555
  • [35] Adjuvant Rosa Damascena has a Small Effect on SSRI-induced Sexual Dysfunction in Female Patients Suffering from MDD
    Farnia, V.
    Hojatitabar, S.
    Shakeri, J.
    Rezaei, M.
    Yazdchi, K.
    Bajoghli, H.
    Holsboer-Trachsler, E.
    Brand, S.
    PHARMACOPSYCHIATRY, 2015, 48 (4-5) : 156 - 163
  • [36] A double-blind, randomized, pilot dose-finding study of maca root (L. Meyenii) for the management of SSRI-Induced sexual dysfunction
    Dording, Christina M.
    Fisher, Lauren
    Papakostas, George
    Farabaugh, Amy
    Sonawalla, Shamsah
    Fava, Maurizio
    Mischoulon, David
    CNS NEUROSCIENCE & THERAPEUTICS, 2008, 14 (03) : 182 - 191
  • [37] Combination risperidone and SSRI-induced serotonin syndrome
    Karki, SD
    Masood, GR
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (03) : 388 - 391
  • [38] Mechanism of SSRI-induced sexual dysfunctions: Preliminary data using male Wistar rats
    Chan, Johnny
    Oosting, Ronald
    Olivier, Berend
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 78 - 78
  • [39] Response to SSRI-induced enuresis - A case report
    Ramadan, MI
    Khan, AY
    Weston, WE
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (01) : 98 - 99
  • [40] Spontaneous remission of SSRI-induced orgasm delay
    Haberfellner, EM
    Rittmannsberger, H
    PHARMACOPSYCHIATRY, 2004, 37 (03) : 127 - 130